Advanced Biomed Inc.
ADVB
$5.10
$0.357.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 31.53% | -26.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 31.06% | -24.30% | |||
| Operating Income | -31.06% | 24.30% | |||
| Income Before Tax | -106.98% | 1,909.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -106.98% | 1,909.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -107.13% | 1,872.53% | |||
| EBIT | -31.06% | 24.30% | |||
| EBITDA | -34.66% | 20.34% | |||
| EPS Basic | -106.00% | 1,872.43% | |||
| Normalized Basic EPS | -19.50% | 10.96% | |||
| EPS Diluted | -106.00% | 1,872.43% | |||
| Normalized Diluted EPS | -19.50% | 10.96% | |||
| Average Basic Shares Outstanding | 18.75% | 0.00% | |||
| Average Diluted Shares Outstanding | 18.75% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||